The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies
Open accessAbstract
Colorectal cancer (CRC) is the second most deadly cancer. Global incidence and mortality are likely to be increased in the coming decades. Although the deaths associated with CRC are very high in high-income countries, the incidence and fatalities related to CRC are growing in developing countries too. CRC detected early is entirely curable by surgery and subsequent medications. However, the recurrence rate is high, and cancer drug resistance increases the treatment failure rate. Access to early diagnosis and treatment of CRC for survival is somewhat possible in developed countries. However, these facilities are rarely available in developing countries. Highlighting the current status of CRC, its development, risk factors, and management is crucial in creating public awareness. Therefore, in this review, we have comprehensively discussed the current global epidemiology, drug resistance, challenges, risk factors, and preventive and treatment strategies of CRC. Additionally, there is a brief discussion on the CRC development pathways and recommendations for preventing and treating CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 CRC new cases and deaths in 2020. (a) shows new cases, both sexes and all ages, and (b) shows deaths of both sexes for all age groups. The value shown in % is calculated against the total number of all cancers. The data source is GLOBOCAN [25], taken with permission.](https://figures.cochat.ai/paper-figures/4cc23fff5e894c79bc57ced9f1c8c3e5/colorectal-cancer-a-review-of-carcinogenesis-global-epidemiology-current-figure-2.jpg)
![Figure 3 Map showing the global distribution of estimated age-standardized incidence rates (top) and mortality rate (bottom) of CRC in 2020 for both sexes and all ages. (Reproduced from GLOBOCAN [25] with permission).](https://figures.cochat.ai/paper-figures/213c6256c3e144b688935fad2866581f/colorectal-cancer-a-review-of-carcinogenesis-global-epidemiology-current-figure-3.jpg)
![Figure 4 World CRC incidence and mortality rates in 2020 (according to income level for all age groups). The data were extracted from GLOBOCAN [25] with permission.](https://figures.cochat.ai/paper-figures/4c8c4ff60d974d3e824dee668004b248/colorectal-cancer-a-review-of-carcinogenesis-global-epidemiology-current-figure-4.jpg)
![Figure 5 World new cases and deaths of colon cancer, rectum cancer, and anus cancer in 2020. (a) New cases and (b) deaths of colon cancer, rectum cancer, and anus cancer. The value is shown in % on top of each column and is calculated against the CRC number in 2020 for both sexes and all ages. Data extracted from GLOBOCAN [25] with permission.](https://figures.cochat.ai/paper-figures/d784f84421274ecdb2a36edfe7578100/colorectal-cancer-a-review-of-carcinogenesis-global-epidemiology-current-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite advancements in these therapeutic modalities, resistance remains a significant challenge, often leading to treatment failure, poor progression-free survival, and cancer recurrence.”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“While overall survival rates for individuals with advanced CRC has increased in recent decades, drug resistance has been reported to develop in nearly all CRC patients [5].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Modifiable factors are associated with the characteristics of a person's lifestyle (obesity, tobacco smoking, alcohol consumption, unhealthy diet)[5-10].”
From Risk factors, prevention and screening of colorectal cancer: A rising problem (2025) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“The development of CRC is associated with the action of non-modifiable and modifiable risk factors.”
From Risk factors, prevention and screening of colorectal cancer: A rising problem (2025) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 5×
“In 2020, CRC was the most diagnosed cancer (out of 36 cancers) among men in 18 of the 186 countries worldwide and women in 6 of the 185 countries [24].”
BackgroundInfluentialBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 2×
“2, which is almost equal to the incidence of 2018 [24,26].”
BackgroundCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111 · cited 1×
“mechanisms herbs and spices exert are the BCL-2, K-ras, and MMP pathways, caspase activation, the extrinsic apoptotic pathway, and the modulation of ER-stress-induced apoptosis chemopreventive effects [162,163].”
BackgroundA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035 · cited 1×
“Currently, there are clinical studies ongoing on some MAbs for CRC, such as adecatumumab against epithelial cell adhesion molecule (EpCAM), labetuzumab against carcinoembryonic antigen (CEA), and pemtumomab against Mucins [133].”
BackgroundPrevention of Colorectal Cancer by Colonoscopic Polypectomy
Winawer, S. J., Zauber, A. G., Ho, M. N., O'Brien, M. J., Gottlieb, L. S., Sternberg, S. S., Waye, J. D., Schapiro, M., Bond, J. H., Panish, J. F., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292701 · Cited by 4,592
Overman, M. J., McDermott, R., Leach, J. L., Lonardi, S., Lenz, H.-J., Morse, M. A., Desai, J., Hill, A., Axelson, M., Moss, R. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30422-9 · Cited by 2,836
Research works printed but not linked: 1
- Urbi, 2014, Grape: A medicinal fruit species in the holy Qur’an and its ethnomedicinal importance, World Appl. Sci. J., 30, 253
Cited by
Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
Li, Q., Geng, S., Luo, H., Wang, W., Mo, Y.-Q., Luo, Q., Wang, L., Song, G.-B., Sheng, J.-P., & Xu, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01953-7 · Cited by 546
Herb and Spices in Colorectal Cancer Prevention and Treatment: A Narrative Review
Hossain, M. S., Kader, M. A., Goh, K. W., Islam, M., Khan, M. S., Harun-Ar Rashid, M., Ooi, D. J., Melo Coutinho, H. D., Al-Worafi, Y. M., Moshawih, S., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865801 · Cited by 346
Self-citationHigh-definition spatial transcriptomic profiling of immune cell populations in colorectal cancer
Oliveira, M. F. D., Romero, J. P., Chung, M., Williams, S. R., Gottscho, A. D., Gupta, A., Pilipauskas, S. E., Mohabbat, S., Raman, N., Sukovich, D. J., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02193-3 · Cited by 321
“Additionally, comparing these metrics with other high-resolution methods like Stereo-seq or Seq-scope could enhance the manuscript's appeal and provide a clearer benchmark for readers.”
Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer
Marino, P., Mininni, M., Deiana, G., Marino, G., Divella, R., Bochicchio, I., Giuliano, A., Lapadula, S., Lettini, A. R., & Sanseverino, F. (2024) · Nutrients · doi:10.3390/nu16060800 · Cited by 240
“There are several factors responsible for its pathology, including environmental factors, genetic factors such as family history, and chronic inflammation, but also factors that include diet and lifestyle [182,183].”
BackgroundDattilo, M., Patitucci, F., Prete, S., Parisi, O. I., & Puoci, F. (2023) · Journal of Functional Biomaterials · doi:10.3390/jfb14020055 · Cited by 174
“Its global incidence is becoming constantly higher, and it is estimated to reach more than double by 2035, especially in less developed nations, where early diagnosis and treatment are rarely available [132].”
Background
Metadata
- Authors
- Hossain, M. S., Karuniawati, H., Jairoun, A. A., Urbi, Z., Ooi, D. J., John, A., Lim, Y. C., Kibria, K. M. K., Mohiuddin, A. K. M., Ming, L. C., Goh, K. W., & Hadi, M. A.
- Affiliations
- International Islamic University Malaysia (MY)
- Universiti Sains Malaysia (MY)
- Universiti Malaysia Pahang Al-Sultan Abdullah (MY)
- Mahsa University (MY)
- Universiti Brunei Darussalam (BN)
- Mawlana Bhashani Science and Technology University (BD)
- INTI International University (MY)
- Qatar University (QA)
- Corresponding author
- Hossain, Md. Sanower
- Ming, Long Chiau
- ORCID
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2022-03-29
- Volume
- 14
- Issue
- 7
- Pages
- 1732
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC8996939
- OpenAlex
- W4220871154
- Semantic Scholar
- a177fa591329da9c54d205f532c08c603177d297
- Cited by
- 920
- References
- 156
- Citations by year
- 2026: 169 · 2025: 307 · 2024: 267 · 2023: 150 · 2022: 23
- FWCI
- 22.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UMP Institutional Repository (Universiti Malaysia Pahang) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Qatar University QSpace (Qatar University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- colorectal cancer, carcinogenesis, global epidemiology, risk factors, cancer prevention, cancer therapy, drug resistance, tumor recurrence, early diagnosis, access to treatment, developing countries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. https://app.cochat.ai/papers/10.3390/cancers14071732
- The paper
- Hossain, M. S., Karuniawati, H., Jairoun, A. A., Urbi, Z., Ooi, D. J., John, A., Lim, Y. C., Kibria, K. M. K., Mohiuddin, A. K. M., Ming, L. C., Goh, K. W., & Hadi, M. A. (2022). Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies. Cancers. https://doi.org/10.3390/cancers14071732
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.